These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38873171)

  • 1. Botulinum toxin injection shows promise in nail psoriasis: A comparative randomized controlled trial.
    Juntongjin P; Srisinlapakig S; Nitayavardhana S
    JAAD Int; 2024 Sep; 16():105-111. PubMed ID: 38873171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: A comparative study.
    Abdelmeniem IM; El Eryan IM; Nofal A; Fouda I; Omar SS
    Dermatol Ther; 2022 Sep; 35(9):e15660. PubMed ID: 35730342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triamcinolone Acetonide Injections in Nail Psoriasis: A Pragmatic Analysis.
    Grover C; Kharghoria G; Bansal S
    Skin Appendage Disord; 2024 Feb; 10(1):50-59. PubMed ID: 38313569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of efficacy and safety of intralesional triamcinolone injection and clobetasol propionate ointment for psoriatic nails.
    Boontaveeyuwat E; Silpa-Archa N; Danchaivijitr N; Wongpraparut C
    J Dermatolog Treat; 2019 Mar; 30(2):117-122. PubMed ID: 29781308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed-dye Laser Versus Intralesional Steroid in the Management of Nail Psoriasis: A Randomized, Intra-patient, Comparative, Controlled Study.
    Soliman M; Aal HA; Sadek AM; Tawfik AA
    J Clin Aesthet Dermatol; 2021 Sep; 14(9):45-49. PubMed ID: 34980971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fractional laser-assisted drug delivery and intralesional injection of triamcinolone acetonide in nail psoriasis.
    Nassar A; Atef H; Eldeeb F; Alakad R
    J Dtsch Dermatol Ges; 2022 Jun; 20(6):788-796. PubMed ID: 35555966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcipotriene/Betamethasone Dipropionate Foam as a Potential Safe and Effective Treatment of Nail Psoriasis.
    Abbas A; Amin S; Sanyi A; Mayo T; Elewski B
    Skin Appendage Disord; 2024 Feb; 10(1):34-36. PubMed ID: 38313566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of nail psoriasis with intralesional triamcinolone acetonide using a needle-free jet injector: a prospective trial.
    Nantel-Battista M; Richer V; Marcil I; Benohanian A
    J Cutan Med Surg; 2014; 18(1):38-42. PubMed ID: 24377472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Efficacy of Triamcinolone Acetonide Iontophoresis versus Topical Calcipotriol/Betamethasone Dipropionate in Treating Nail Psoriasis: A Bilateral Controlled Clinical Trial.
    Saki N; Hosseinpoor S; Heiran A; Mohammadi A; Zeraatpishe M
    Dermatol Res Pract; 2018; 2018():2637691. PubMed ID: 30584420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramatricial injections for nail psoriasis: An open-label comparative study of triamcinolone, methotrexate, and cyclosporine.
    Mittal J; Mahajan BB
    Indian J Dermatol Venereol Leprol; 2018; 84(4):419-423. PubMed ID: 29536977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel transdermal device for delivery of triamcinolone for nail psoriasis treatment.
    Yew YW; Phuan CZY; Zhao X; Tan EST; Chong WS; Tey HL
    Ann Acad Med Singap; 2022 Jan; 51(1):16-23. PubMed ID: 35091727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of psoriatic onychodystrophy by a water-soluble nail lacquer.
    Cantoresi F; Sorgi P; Arcese A; Bidoli A; Bruni F; Carnevale C; Calvieri S
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):832-4. PubMed ID: 19470045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for nail psoriasis.
    de Vries AC; Bogaards NA; Hooft L; Velema M; Pasch M; Lebwohl M; Spuls PI
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007633. PubMed ID: 23440816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of nail psoriasis with adalimumab: an open label unblinded study.
    Rigopoulos D; Gregoriou S; Lazaridou E; Belyayeva E; Apalla Z; Makris M; Katsambas A; Ioannides D
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):530-4. PubMed ID: 19807825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
    Huang YC; Chou CL; Chiang YY
    Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial.
    Reich K; Sullivan J; Arenberger P; Mrowietz U; Jazayeri S; Augustin M; Parneix A; Regnault P; You R; Milutinovic M
    Br J Dermatol; 2019 Nov; 181(5):954-966. PubMed ID: 30367462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional CO2 Laser-Assisted Delivery Versus Intralesional Injection of Methotrexate in Psoriatic Nails.
    Alakad R; Nassar A; Atef H; Eldeeb F
    Dermatol Surg; 2022 May; 48(5):539-544. PubMed ID: 35333217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1.
    Rich P; Bourcier M; Sofen H; Fakharzadeh S; Wasfi Y; Wang Y; Kerkmann U; Ghislain PD; Poulin Y;
    Br J Dermatol; 2014 Feb; 170(2):398-407. PubMed ID: 24117389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intense pulsed light versus pulsed dye laser in the treatment of nail psoriasis: Intra-patient left to right comparative controlled study.
    Morsy EE; Mohamed R; Omar SI
    Indian J Dermatol Venereol Leprol; 2024 Apr; ():1-9. PubMed ID: 38841963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial.
    Tillett W; Egeberg A; Sonkoly E; Gorecki P; Tjärnlund A; Buyze J; Wegner S; McGonagle D
    Arthritis Res Ther; 2023 Sep; 25(1):169. PubMed ID: 37715294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.